KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Restructuring Costs (2016 - 2025)

Merck (MRK) has disclosed Restructuring Costs for 17 consecutive years, with $213.0 million as the latest value for Q4 2025.

  • Quarterly Restructuring Costs rose 317.65% to $213.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $889.0 million through Dec 2025, up 186.77% year-over-year, with the annual reading at $889.0 million for FY2025, 187.7% up from the prior year.
  • Restructuring Costs for Q4 2025 was $213.0 million at Merck, up from $47.0 million in the prior quarter.
  • The five-year high for Restructuring Costs was $560.0 million in Q2 2025, with the low at $47.0 million in Q3 2025.
  • Average Restructuring Costs over 5 years is $139.8 million, with a median of $100.5 million recorded in 2021.
  • The sharpest move saw Restructuring Costs tumbled 82.15% in 2022, then surged 600.0% in 2025.
  • Over 5 years, Restructuring Costs stood at $174.0 million in 2021, then crashed by 71.84% to $49.0 million in 2022, then skyrocketed by 420.41% to $255.0 million in 2023, then tumbled by 80.0% to $51.0 million in 2024, then soared by 317.65% to $213.0 million in 2025.
  • According to Business Quant data, Restructuring Costs over the past three periods came in at $213.0 million, $47.0 million, and $560.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.